RCT | Ivermectin does not improve time to recovery in outpatients with mild to moderate COVID-19.

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial – JAMA

Commentary: Ivermectin doesn’t speed time to recovery from nonsevere COVID – CIDRAP

Commentary on Twitter

Study findings do not support the use of #ivermectin in outpatients with mild to moderate #COVID19. https://t.co/do8zbVkeLK #Research

— JAMA (@JAMA_current) October 21, 2022